Results
eNauka >
Results >
APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Title: | APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM) | Authors: | Einsele, H; ...; Bila, Jelena S ![]() ![]() |
Issue Date: | 2021 | Publication: | ONCOLOGY RESEARCH AND TREATMENT | ISSN: | 2296-5270![]() ![]() |
Type: | Conference Paper | Collation: | vol. 44 str. 178-178 | WoS-ID: | 000760622600326 | URI: | https://enauka.gov.rs/handle/123456789/823634 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.